Le Lézard
Classified in: Health
Subjects: PDT, VET, DEI

Warrior Centric Health Launches Population Health Mission with Air Force's 59th Medical Wing


ELLICOTT CITY, Md., Oct. 12, 2021 /PRNewswire/ -- Warrior Centric Health (WCH)® has launched work on a contract to adapt its commercial population health management solution to serve the Air Force's flagship 59th Medical Wing, located at Joint Base San Antonio, Texas. This vital project grew out of the Defense Health Agency's ambitious Quadruple Aim Performance Plan (Quad Aim), which was intended to improve Warfighter readiness by providing better care, leading to better health, at lower cost.

Warrior Centric Health® is adapting its population health management solution to serve the Air Force's 59th Medical Wing

WCH Helps Deliver on Quad Aim's Promise
A key objective of Quad Aim is implementation of population-based health strategies that specifically target active-duty service members, retirees, and their families who receive care in Military Health Facilities (MTFs). WCH has devoted over a decade of research and development into precisely that: a population health management platform that integrates data science, e-learning, professional credentialing, community outreach, and facility authorization with the specific aim of helping healthcare facilities optimize care for their Warrior Communities. This industry-leading solution is already gaining traction in the commercial sector.

The project will adapt WCH's existing platform to achieve measurable results in the military healthcare setting. Through their combined efforts, other MTFs will soon be able to adopt the new Military Model of WCH's population health management solution to fulfill their own Quad Aim objectives.

Says Ron Steptoe, CEO and Founder of Warrior Centric Health: 
"Everyone at Warrior Centric Health is looking forward to working with the 59th Medical Wing. This is a huge opportunity to prove out our platform in a military setting. And there is no organization more prepared to make it happen than the 59th MDW."

SBIR ? "America's Seed Fund"? Makes it Possible
The contract between the 59th MDW and WCH is a "SBIR Phase II" contract made possible by the Small Business Innovation Research program.

SBIR is intended to enable federal buyers, such as the Air Force, to purchase ready-made technologies quickly, efficiently, and cost-effectively, and adapt them to their own uses, while the small businesses that develop the technologies get the advantages of both a ready buyer and development partner.

WCH's SBIR efforts are sponsored by the Air Force Research Laboratory (AFRL), which has partnered with U.S. Air Force (AFWERX) to streamline the SBIR process.

Because of SBIR, WCH and the 59th MDW will deliver the population-based health solution the military needs, while WCH continuously improves its solution for both the military and commercial healthcare markets.

The 59th is the Air Force's Flagship Medical Wing
The 59th Medical Wing is the largest medical wing in the Air Force, composed of six groups across the $1.2 billion San Antonio Military Health System, Joint Base San Antonio. the 59th MDW supports more than 240,000 beneficiaries with more than 6,000 military and civilian personnel, residents, and students

About Warrior Centric Health, LLC
Warrior Centric Health (WCH)® provides hospitals and health systems with a groundbreaking digital platform that enables them to deliver comprehensive, best-practice population health management to the vast Warrior Community. It is the only fully realized population health solution of its kind. WCH is a Supplier Diversity - Certified Veteran's Business Enterprisetm, a Vizient® Awarded Supplier, and a Microsoft for Startups® company. Please visit https://warriorcentrichealth.com or follow the company on Twitter, LinkedIn, and Facebook.

Contact:
For Information
Ron Steptoe, CEO
[email protected]

For Media Inquiries
David Collier, COO
[email protected]

SOURCE Warrior Centric Health, LLC


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: